Related Experiment Video
Updated: Oct 26, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.7K
Next-Generation Immunotherapy Approaches in Melanoma
Tyler Buchanan1, Afsaneh Amouzegar1, Jason J Luke2,3
1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Current Oncology Reports
|August 3, 2021
Summary
Immune checkpoint inhibitors have transformed metastatic melanoma treatment. This review covers current and emerging immunotherapies, including promising next-generation agents in clinical trials.
Area of Science:
- Oncology
- Immunology
Background:
- Immune checkpoint inhibition has significantly improved outcomes for patients with metastatic melanoma.
- Despite advancements, there is a critical need for novel therapeutics for patients experiencing disease progression on current treatments.
Purpose of the Study:
- To review current and next-generation immune-based anti-cancer therapeutics for metastatic melanoma.
- To highlight the evolving landscape of immuno-oncology in melanoma treatment.
Main Methods:
- Literature review of current and emerging immuno-oncology agents.
- Analysis of clinical trial data for novel immunotherapies.
Main Results:
- Several novel agents are anticipated for FDA approval, showing impressive response rates.
- The field of immuno-oncology is rapidly expanding with agents possessing novel mechanisms of action.
Conclusions:
- The next generation of immunotherapies, built on extensive research, shows promising preliminary data in early phase trials.
- Continued development in immuno-oncology offers hope for patients with refractory metastatic melanoma.
Related Concept Videos
01:27Tumor Immunotherapy
778
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
01:30Cancer Vaccines
581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:50Combination Therapies and Personalized Medicine
5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
01:27Cytotoxic T Cells-mediated Immune Response
5.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.2K